These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 32535544)

  • 1. Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions.
    Apostolova N; Iannantuoni F; Gruevska A; Muntane J; Rocha M; Victor VM
    Redox Biol; 2020 Jul; 34():101517. PubMed ID: 32535544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Metformin Protect Diabetic Patients from Oxidative Stress and Leukocyte-Endothelium Interactions?
    Diaz-Morales N; Rovira-Llopis S; Bañuls C; Lopez-Domenech S; Escribano-Lopez I; Veses S; Jover A; Rocha M; Hernandez-Mijares A; Victor VM
    Antioxid Redox Signal; 2017 Dec; 27(17):1439-1445. PubMed ID: 28467723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Metformin Modulate Mitochondrial Dynamics and Function in Type 2 Diabetic Patients?
    de Marañón AM; Canet F; Abad-Jiménez Z; Jover A; Morillas C; Rocha M; Victor VM
    Antioxid Redox Signal; 2021 Aug; 35(5):377-385. PubMed ID: 33559513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients.
    Escribano-Lopez I; Diaz-Morales N; Rovira-Llopis S; de Marañon AM; Orden S; Alvarez A; Bañuls C; Rocha M; Murphy MP; Hernandez-Mijares A; Victor VM
    Redox Biol; 2016 Dec; 10():200-205. PubMed ID: 27810734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes.
    Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; de Marañon AM; Abad-Jimenez Z; Bañuls C; Rovira-Llopis S; Herance JR; Rocha M; Victor VM
    Sci Rep; 2018 Oct; 8(1):15862. PubMed ID: 30367115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin--mode of action and clinical implications for diabetes and cancer.
    Pernicova I; Korbonits M
    Nat Rev Endocrinol; 2014 Mar; 10(3):143-56. PubMed ID: 24393785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium.
    Kinaan M; Ding H; Triggle CR
    Med Princ Pract; 2015; 24(5):401-15. PubMed ID: 26021280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of action of metformin: old or new insights?
    Rena G; Pearson ER; Sakamoto K
    Diabetologia; 2013 Sep; 56(9):1898-906. PubMed ID: 23835523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and Molecular Mechanisms of Metformin Action.
    LaMoia TE; Shulman GI
    Endocr Rev; 2021 Jan; 42(1):77-96. PubMed ID: 32897388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of action of metformin: latest advances and therapeutic implications.
    Zhu H; Jia Z; Li YR; Danelisen I
    Clin Exp Med; 2023 Nov; 23(7):2941-2951. PubMed ID: 37016064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin: from mechanisms of action to therapies.
    Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
    Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammatory effect of metformin: The molecular targets.
    Sakata N
    Genes Cells; 2024 Mar; 29(3):183-191. PubMed ID: 38311861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin: Is it a drug for all reasons and diseases?
    Triggle CR; Mohammed I; Bshesh K; Marei I; Ye K; Ding H; MacDonald R; Hollenberg MD; Hill MA
    Metabolism; 2022 Aug; 133():155223. PubMed ID: 35640743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.
    Madiraju AK; Erion DM; Rahimi Y; Zhang XM; Braddock DT; Albright RA; Prigaro BJ; Wood JL; Bhanot S; MacDonald MJ; Jurczak MJ; Camporez JP; Lee HY; Cline GW; Samuel VT; Kibbey RG; Shulman GI
    Nature; 2014 Jun; 510(7506):542-6. PubMed ID: 24847880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice.
    Zhao X; Zhang X; Pei J; Liu Y; Niu W; Sun H
    Diabetologia; 2023 Nov; 66(11):2139-2153. PubMed ID: 37581618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin promotes mitophagy in mononuclear cells: a potential in vitro model for unraveling metformin's mechanism of action.
    Bhansali S; Bhansali A; Dhawan V
    Ann N Y Acad Sci; 2020 Mar; 1463(1):23-36. PubMed ID: 31225649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect.
    Picone P; Nuzzo D; Caruana L; Messina E; Barera A; Vasto S; Di Carlo M
    Biochim Biophys Acta; 2015 May; 1853(5):1046-59. PubMed ID: 25667085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.